A prospective cohort study of Yangyin moisturizing ointment to intervene in patients with psoriasis vulgaris recurrence

Guang'anmen Hospital, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•Inclusion criteria for patients with psoriasis
•(1) Meet the diagnostic criteria for plaque psoriasis vulgaris;
•(2) 18 years old< age = 70 years old;
•(3) Standardized injection of secukinumab injection for more than 12 weeks, 4~8 weeks after the last injection, and the willingness to stop the drug;
•(4) PGA score =1, BSA =3%;
•(5) Signed informed consent and willing to accept follow-up. Inclusion Criteria for Healthy Subjects.
•Healthy control group: healthy subjects who will visit the China Academy of Chinese Medical Sciences from January 1, 2024 to November 1, 2026 The inclusion criteria are as follows:
•(1) 18 years old< age = 70 years old;
•(2) Persons with a physical examination (without a clear diagnosis of disease);
•(3) Sign the informed consent form.

•Exclusion criteria for patients with psoriasis
•(1) Pregnant, planning pregnancy and lactating women;
•(2) Systemic glucocorticoids, immunosuppressants, and retinoids within 4 weeks;
•(3) Patients with severe liver and kidney insufficiency;
•(4) Patients with severe mental illness;
•(5) Participated in other clinical trials in the past three months.
•Exclusion criteria for healthy subjects
•(1) Pregnant, planning pregnancy and lactating women;
•(2) Participated in other clinical trials in the past three months.

发起方